Sourced from:Manufacturer Authorized Distributor
Quick Summary
Cilacar NB 2.5mg Tablet
Last updated on 30 Jul 2026 | 06:34 AM (IST)
₹141
MRP: ₹165.69
(You Save ₹24.69)
10 TABLET(s) IN A STRIP
Cilacar NB 2.5 mg Tablet is a prescription medicine used to treat high blood pressure (hypertension). It contains cilnidipine and nebivolol, which work together to relax blood vessels and reduce heart rate, helping to lower blood pressure and reduce strain on the heart. Cilacar NB 2.5 mg Tablet should be taken under strict medical supervision as part of a comprehensive cardiovascular care plan.
Sourced from:Manufacturer Authorized Distributor
15% OFF
₹141
MRP: ₹165.69
Inclusive of all taxes
15% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Introduction to Cilacar NB 2.5mg Tablet
Cilacar NB 2.5mg tablet belongs to the group of medications called antihypertensives. It contains a combination of Cilnidipine and Nebivolol, which is primarily used for controls blood pressure when a single medication is ineffective. Hypertension (high blood pressure) is a medical condition in which blood exerts a force on the artery walls (blood vessels), resulting in heart disease, irregular heartbeat, and other problems.
The common symptoms likely associated with Cilacar NB 2.5mg tablet are headache, constipation, cold extremities, nausea, sleepiness, tiredness, palpitations, ankle swelling, flushing (warm cheeks, necks, ears), edema (swelling), dizziness, increased frequency of urination, lethargy, an unusual feeling of itching or tingling and shortness of breath. Inform your healthcare provider if these side effects disturb or persist in you.
Inform your physician if you are allergic to Cilnidipine, Nebivolol, and its ingredients. Before treatment with Cilacar NB 2.5mg tablet, let your physician know if you have low blood pressure (hypotension), diabetes, cardiogenic shock (sudden stopping of blood flow to the heart), hyperthyroidism (overactivity of the thyroid gland), Raynaud's disease (poor circulation in arms or legs), phaeochromocytoma and chronic bronchitis. Hence, your doctor may regularly monitor your blood pressure, electrolytes, and potassium level in your blood at regular intervals. It should not be given to children less than 12 years of age.
Uses of Cilacar NB 2.5mg Tablet
- Treatment of essential hypertension (high blood pressure).
Therapeutic Effects of Cilacar NB 2.5mg Tablet
Cilnidipine acts by blocking both L- and N-type calcium channels which relaxes the blood vessels. It helps lower blood pressure, making the heart's pumping action more effective and the blood flow more smoothly. Nebivolol works by reducing heart rate and relaxing blood vessels to enhance blood circulation and reduce blood pressure. Together, they treat people with hypertension who cannot be managed with a single medication.
Interaction of Cilacar NB 2.5mg Tablet with other drugs
Inform your physician about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Cilacar NB 2.5mg tablet and cause undesirable side effects.
More Information about Cilacar NB 2.5mg Tablet
- Store at a temperature not exceeding 30ºC.
- Protect from light & moisture.
- Keep Cilacar NB 2.5mg tablet out of sight and reach of children.
How to consume Cilacar NB 2.5mg Tablet
Cilacar NB 2.5mg tablet can be taken with food or without food. It should be swallowed whole with a glass of water. Do not chew, crush, or break it. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
Safety Advice for Cilacar NB 2.5mg Tablet
Breast Feeding
Breastfeeding is not recommended in women who are HIV positive and taking Cilacar NB 2.5mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Alcohol
Avoid consuming alcohol while taking Cilacar NB 2.5mg tablet, as it can decrease blood pressure and increase unpleasant side effects.
Liver
Cilacar NB 2.5mg tablet should be cautiously administered in patients with liver diseases. Dose adjustments are necessary. However, inform your physician of any liver diseases before initiating the therapy.
Lungs
It is unknown whether Cilacar NB 2.5mg tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
Driving
Do not drive or operate machinery because Cilacar NB 2.5mg tablet can cause dizziness or tiredness (fatigue).
Pregnancy
Do not take Cilacar NB 2.5mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment.
Side Effects of Cilacar NB 2.5mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.
Common
- Headache
- Constipation
- Cold extremities
- Nausea
- Sleepiness
- Tiredness, lethargy
- Palpitations
- Ankle swelling
- Flushing (warm cheeks, necks, ears)
- Edema (swelling)
- Dizziness
- Increased frequency of urination
- Unusual feeling of itching or tingling
- Shortness of breath
Word of Advice
Before initiating treatment with Cilacar NB 2.5mg tablet, it's crucial to inform your doctor if you have any allergies to Cilnidipine, Nebivolol, or any of the components present in the formulation. Additionally, disclose if you have underlying conditions such as diabetes, heart issues, lung disease, or lactose intolerance.This medicine should be used caution in patients with severe kidney disease. Dose adjustment is required based on the kidney condition.
It is advised to monitor your blood pressure regularly. It would be best to have potassium and electrolytes check-ups while taking Cilacar NB 2.5mg tablet to prevent complications. Do not take this medication if a patient has asthma, wheezing, or a tumor in the adrenal gland. Taking a low-salt diet and regular exercise is recommended for better results.
FAQs about Cilacar NB 2.5mg Tablet
Q1.
What class of medication is Cilacar NB 2.5mg tablet?
Cilacar NB 2.5mg tablet belongs to an antihypertensive medication class.
Q2.
Is children use Cilacar NB 2.5mg tablet?
No, Cilacar NB 2.5mg tablet is not recommended for children less than 12 years of age.
Q3.
How do I store Cilacar NB 2.5mg tablet?
Cilacar NB 2.5mg tablet is stored below 30°C and protects them from light and moisture. Keep this medication out of sight and reach of children.
Q4.
What happens when I stop taking Cilacar NB 2.5mg tablet?
Sudden withdrawal of Cilacar NB 2.5mg tablet may raise your blood pressure and increase the risk of heart disease and stroke. Hence, it is necessary to consult your doctor before withdrawing this medication.
Q5.
Is Cilacar NB 2.5mg tablet safe during pregnancy?
No, Cilacar NB 2.5mg tablet should not be used during pregnancy because it may cause harmful effects on the developing fetus.
Q6.
Why has Cilacar NB 2.5mg tablet been prescribed to me?
Cilacar NB 2.5mg tablet is an antihypertensive medication. It has been prescribed to treat hypertension (high blood pressure).
Q7.
What should I do if I forget to take Cilacar NB 2.5mg tablet?
When you remember, take Cilacar NB 2.5mg tablet right away. Skip the missed dose if it is almost time for your next one, and continue with your regular dosing schedule. Do not take a double dose to make up for a missing one.
Fact Box of Cilacar NB 2.5mg Tablet
Molecule name: Cilnidipine+ Nebivolol | Therapeutic class: Antihypertensive drugs |
Pharmacological class: 1. Calcium channel blocker 2. Beta-blocker | Indications: Treats hypertension |
References
- KD Tripathi, Essentials of Medical Pharmacology, Antiadrenergic Drugs and Drugs for Glaucoma, 7th Edition, 2013, 148-149.
- Torrent Pharmaceuticals, Nebicard LN. Nebivolol Hydrochloride & Cilnidipine Tablet, [Revised in February 2022] [Accessed on 18th August 2023], https://www.torrentian.com/pisheet/Upload/PI_Sheet/2995.pdf
- Forest Pharmaceuticals Inc., US Food and Drug Administration, [ Revised on December 2011] [ Accessed on 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021742s013lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Aswini Priya Velmurugan
PG in Biotechnology
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 30 Jul 2026 | 06:34 AM (IST)
Want to know more?
Read Our Editorial Policy
